Cargando…

Enhanced Anti-Cancer Effect of Folate-Conjugated Olaparib Nanoparticles Combined with Radiotherapy in Cervical Carcinoma

BACKGROUND: Radiotherapy (RT), one of the main treatments for cervical cancer, has tremendous potential for improvement in the efficacy. Poly (ADP-ribose) polymerase (PARP) is a key enzyme in the repair of DNA strand breaks (DSB). Olaparib (Ola) is a PARP inhibitor that is involved in preventing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dong, Hu, Chuanfei, Yang, Juan, Liao, Yin, Chen, Yue, Fu, Shao Zhi, Wu, Jing Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735794/ https://www.ncbi.nlm.nih.gov/pubmed/33328733 http://dx.doi.org/10.2147/IJN.S272730

Ejemplares similares

Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
por: Wu, Min, et al.
Publicado: (2018)

In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
por: Yu, YanXin, et al.
Publicado: (2017)

Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study
por: Sheikh, Hamid, et al.
Publicado: (2023)

Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer
por: Jiang, Yi-Ling, et al.
Publicado: (2023)

Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
por: Quiñonero, Francisco, et al.
Publicado: (2023)

Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism
por: Yang, Hong, et al.
Publicado: (2011)

Enhanced Antiproliferative Effect of Carboplatin in Cervical Cancer Cells Utilizing Folate-Grafted Polymeric Nanoparticles
por: Ji, Jing, et al.
Publicado: (2015)

Targeted images of KB cells using folate-conjugated gold nanoparticles
por: Rathinaraj, Pierson, et al.
Publicado: (2015)

Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer
por: Liao, Tian-tian, et al.
Publicado: (2021)

A step-wise synthetic approach is necessary to access γ-conjugates of folate: folate-conjugated prodigiosenes
por: Figliola, Carlotta, et al.
Publicado: (2019)

The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles()
por: Chen, Daozhen, et al.
Publicado: (2010)

The combination of olaparib and camptothecin for effective radiosensitization
por: Miura, Katsutoshi, et al.
Publicado: (2012)

Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells
por: Shi, Yijie, et al.
Publicado: (2014)

Combining Dextran Conjugates with Stimuli-Responsive and Folate-Targeting Activity: A New Class of Multifunctional Nanoparticles for Cancer Therapy
por: Curcio, Manuela, et al.
Publicado: (2021)

Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells
por: Herdiana, Yedi, et al.
Publicado: (2023)

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
por: de Haan, R., et al.
Publicado: (2019)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status
por: Fulton, Ben, et al.
Publicado: (2017)

A Comparative Study of Two Folate-Conjugated Gold Nanoparticles for Cancer Nanotechnology Applications
por: Mansoori, G. Ali, et al.
Publicado: (2010)

Enhancement of Binding Affinity of Folate to Its Receptor by Peptide Conjugation
por: Dharmatti, Roopa, et al.
Publicado: (2019)

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
por: Liu, Chuan, et al.
Publicado: (2020)

Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)
por: Mahdi, Haider, et al.
Publicado: (2021)

Functional coating of liposomes using a folate– polymer conjugate to target folate receptors
por: Watanabe, Kazuo, et al.
Publicado: (2012)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
por: Navran, Arash, et al.
Publicado: (2023)

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells
por: Qin, Changjiang, et al.
Publicado: (2022)

Combinations of radiotherapy with immunotherapy in cervical cancer
por: Yang, Xiaojing, et al.
Publicado: (2022)

Investigating the Cytotoxicity of Folate-Conjugated Bismuth Oxide Nanoparticles on KB and A549 Cell Lines
por: Akbarzadeh, Fatemeh, et al.
Publicado: (2018)

Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles
por: Gui, Gang, et al.
Publicado: (2021)

Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
por: Prasad, Chandra Bhushan, et al.
Publicado: (2017)

Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs
por: Feng, Shini, et al.
Publicado: (2016)

Folate and Borneol Modified Bifunctional Nanoparticles for Enhanced Oral Absorption
por: Yang, Yifan, et al.
Publicado: (2018)

Folate Receptor-targeted Bioflavonoid Genistein-loaded Chitosan Nanoparticles for Enhanced Anticancer Effect in Cervical Cancers
por: Cai, Limei, et al.
Publicado: (2017)

Copolymer-Green-Synthesized Copper Oxide Nanoparticles Enhance Folate-Targeting in Cervical Cancer Cells In Vitro
por: Jagaran, Keelan, et al.
Publicado: (2023)

Synthesis of folate-chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells
por: Cheng, Lichun, et al.
Publicado: (2017)

Preparation and biodistribution of (188)Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles ((188)Re-folate-CDDP/HSA MNPs) in vivo
por: Tang, Qiu-Sha, et al.
Publicado: (2011)

Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model
por: Wickstroem, Katrine, et al.
Publicado: (2019)

Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib
por: Gross, Maya, et al.
Publicado: (2022)

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
por: Burgess, Brian T., et al.
Publicado: (2020)

Rational Fabrication of Folate-Conjugated Zein/Soy Lecithin/Carboxymethyl Chitosan Core–Shell Nanoparticles for Delivery of Docetaxel
por: Wu, Zhenyao, et al.
Publicado: (2022)

Facile synthesis of folate-conjugated magnetic/fluorescent bifunctional microspheres
por: Shen, Mao, et al.
Publicado: (2014)

Folate-conjugated polyspermine for lung cancer–targeted gene therapy
por: Zhang, Mei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_teccevt910505tdr6uqu7m8phf